134 related articles for article (PubMed ID: 37897380)
21. Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry.
Kotalczyk A; Guo Y; Stefil M; Wang Y; Lip GYH;
J Am Heart Assoc; 2022 Apr; 11(7):e024319. PubMed ID: 35377169
[TBL] [Abstract][Full Text] [Related]
22. Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns.
Vos R; Boesten J; van den Akker M
PLoS One; 2022; 17(2):e0264343. PubMed ID: 35213615
[TBL] [Abstract][Full Text] [Related]
23. Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan.
Aoki T; Fujinuma Y; Matsushima M
BMJ Open; 2022 Jan; 12(1):e054348. PubMed ID: 34996796
[TBL] [Abstract][Full Text] [Related]
24. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada.
Maxwell CJ; Mondor L; Pefoyo Koné AJ; Hogan DB; Wodchis WP
PLoS One; 2021; 16(4):e0250567. PubMed ID: 33901232
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
Hasan Ibrahim AS; Barry HE; Hughes CM
Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
[TBL] [Abstract][Full Text] [Related]
27. What influences prescribing decisions in a multimorbidity and polypharmacy context on the acute medical unit? An interprofessional, qualitative study.
Rivers PH; Langford N; Whitehead A; Harrison T
J Eval Clin Pract; 2021 Oct; 27(5):1076-1084. PubMed ID: 33314589
[TBL] [Abstract][Full Text] [Related]
28. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
[TBL] [Abstract][Full Text] [Related]
29. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
30. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
McQueenie R; Foster HME; Jani BD; Katikireddi SV; Sattar N; Pell JP; Ho FK; Niedzwiedz CL; Hastie CE; Anderson J; Mark PB; Sullivan M; O'Donnell CA; Mair FS; Nicholl BI
PLoS One; 2020; 15(8):e0238091. PubMed ID: 32817712
[TBL] [Abstract][Full Text] [Related]
31. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
[TBL] [Abstract][Full Text] [Related]
32. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
[TBL] [Abstract][Full Text] [Related]
33. Is polypharmacy beneficial or detrimental for older adults with cardiometabolic multimorbidity? Pooled analysis of studies from Hong Kong and Europe.
Cheung JTK; Yu R; Woo J
Fam Pract; 2020 Nov; 37(6):793-800. PubMed ID: 32596732
[TBL] [Abstract][Full Text] [Related]
34. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study.
Lozano-Hernández CM; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; Barrio-Cortes J; Gimeno-Feliu LA; Poblador-Plou B; Cura-González ID;
PLoS One; 2020; 15(6):e0235148. PubMed ID: 32579616
[TBL] [Abstract][Full Text] [Related]
35. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
[TBL] [Abstract][Full Text] [Related]
36. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
37. Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator.
Assari S; Wisseh C; Bazargan M
Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31226752
[TBL] [Abstract][Full Text] [Related]
38. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
[TBL] [Abstract][Full Text] [Related]
39. Associations between Polypharmacy, Self-Rated Health, and Depression in African American Older Adults; Mediators and Moderators.
Bazargan M; Smith J; Saqib M; Helmi H; Assari S
Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31064059
[No Abstract] [Full Text] [Related]
40. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
Rhee TG; Rosenheck RA
J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
